Cases & Deals

  • Home
  • Practices
  • Otsuka acquires new, high-sensitivity biomarker measurement technology from Konica Minolta

Share

Otsuka acquires new, high-sensitivity biomarker measurement technology from Konica Minolta

September 2021

Client(s) Otsuka Pharmaceutical Co., Ltd.

Jones Day advised Otsuka Pharmaceutical Co., Ltd. in the acquisition of Konica Minolta's new high-sensitivity biomarker measurement technology that uses SPFS (surface plasmon field-enhanced fluorescence spectroscopy) technology.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.